Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
US7291637B2 · kind B2 · utility
0Cited by
119References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 2005 |
| Grant date | Nov 6, 2007 |
| Priority date | — |
| Expiry date | Feb 4, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D275/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.